Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Serum Potassium Levels and Renal Function in Ambulatory Outpatients: Risk Factors Analysis
- 1 October 2008
- journal article
- research article
- Published by Elsevier BV in The American Journal of the Medical Sciences
- Vol. 336 (4), 330-335
- https://doi.org/10.1097/maj.0b013e3181836ac7
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Combination Therapy With an Angiotensin Receptor Blocker and an ACE Inhibitor in Proteinuric Renal Disease: A Systematic Review of the Efficacy and Safety DataAmerican Journal of Kidney Diseases, 2006
- Efficacy and Safety of Benazepril for Advanced Chronic Renal InsufficiencyThe New England Journal of Medicine, 2006
- The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2001
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesThe New England Journal of Medicine, 2001
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyThe New England Journal of Medicine, 2001
- Hyperkalemia in Outpatients Using Angiotensin-Converting Enzyme InhibitorsArchives of Internal Medicine, 1998
- Effect of Captopril on Progression to Clinical Proteinuria in Patients With Insulin-Dependent Diabetes Mellitus and MicroalbuminuriaJama-Journal Of The American Medical Association, 1994
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyThe New England Journal of Medicine, 1993
- Long-Term Stabilizing Effect of Angiotensin-Converting Enzyme Inhibition on Plasma Creatinine and on Proteinuria in Normotensive Type II Diabetic PatientsAnnals of Internal Medicine, 1993
- Efficacy and safety of cilazapril in hypertensive patients with moderate to severe renal impairmentAmerican Journal Of Medicine, 1989